Rafferty Asset Management’s Zimmer Biomet ZBH Stock Holding History

Rafferty Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.38M	Sell	15,311 -6,028	-28%	-$553K	0.01%	690
2025 Q4	$1.92M	Sell	21,339 -658	-3%	-$62.4K	0.01%	655
2025 Q3	$2.17M	Buy	21,997 +1,079	+5%	+$107K	0.01%	633
2025 Q2	$1.91M	Buy	20,918 +2,487	+13%	+$240K	0.01%	615
2025 Q1	$2.09M	Sell	18,431 -4,149	-18%	-$444K	0.01%	569
2024 Q4	$2.39M	Buy	22,580 +1,925	+9%	+$207K	0.01%	595
2024 Q3	$2.23M	Sell	20,655 -1,721	-8%	-$188K	0.01%	601
2024 Q2	$2.43M	Buy	22,376 +794	+4%	+$93.6K	0.01%	590
2024 Q1	$2.85M	Buy	21,582 +305	+1%	+$38.1K	0.01%	597
2023 Q4	$2.59M	Sell	21,277 -527	-2%	-$58.8K	0.01%	608
2023 Q3	$2.45M	Buy	21,804 +1,570	+8%	+$199K	0.01%	556
2023 Q2	$2.95M	Buy	20,234 +1,458	+8%	+$198K	0.02%	533
2023 Q1	$2.43M	Buy	18,776 +738	+4%	+$92.7K	0.02%	550
2022 Q4	$2.3M	Buy	18,038 +6,800	+61%	+$789K	0.02%	536
2022 Q3	$1.18M	Buy	11,238 +6,153	+121%	+$675K	0.01%	623
2022 Q2	$534K	Sell	5,085 -1,300	-20%	-$154K	﹤0.01%	791
2022 Q1	$817K	Sell	6,385 -847	-12%	-$102K	﹤0.01%	824
2021 Q4	$892K	Buy	7,232 +373	+5%	+$48.8K	﹤0.01%	924
2021 Q3	$975K	Buy	6,859 +2,415	+54%	+$355K	0.01%	838
2021 Q2	$694K	Buy	4,444 +404	+10%	+$65.4K	﹤0.01%	1002
2021 Q1	$628K	Buy	4,040 +520	+15%	+$80.5K	﹤0.01%	925
2020 Q4	$527K	Sell	3,520 -329	-9%	-$46.5K	0.01%	671
2020 Q3	$509K	Sell	3,849 -942	-20%	-$123K	0.01%	690
2020 Q2	$555K	Buy	+4,791	New	+$552K	0.01%	689
2020 Q1	–	Sell	-5,721	Closed	-$831K	–	820
2019 Q4	$831K	Buy	+5,721	New	+$790K	0.01%	589
2019 Q2	–	Sell	-4,809	Closed	-$596K	–	858
2019 Q1	$596K	Buy	+4,809	New	+$546K	0.01%	633
2015 Q4	–	Sell	-4,835	Closed	-$441K	–	599
2015 Q3	$441K	Buy	+4,835	New	+$485K	0.03%	407

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rafferty Asset Management's ZBH Position: Q1 2026 in Review

Rafferty Asset Management reduced its Zimmer Biomet (ZBH) stake by 28% in Q1 2026, selling an estimated $553K and leaving 15,311 shares worth $1.38M. The position accounts for 0.01% of the portfolio, ranked #690.

Rafferty Asset Management first reported a position in ZBH in Q3 2015 and has held it in 27 quarters since. The position peaked at $2.95M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Rafferty Asset Management held 15,311 shares of Zimmer Biomet worth $1.38M as of Q1 2026.
Rafferty Asset Management sold 6,028 Zimmer Biomet shares in Q1 2026, an estimated $553K.
Zimmer Biomet made up 0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #690 holding.
Rafferty Asset Management first reported a position in Zimmer Biomet in Q3 2015 and has held it in 27 quarters since.
Rafferty Asset Management's Zimmer Biomet position peaked at $2.95M in Q2 2023.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.